Diabetic Macular Edema Dme clinical trials

Explore recruiting diabetic macular edema dme clinical trials.

Recruiting diabetic macular edema dme studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Macular Edema Dme trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3 Double-masked, Randomized, 2-stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

Spain, Hungary

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea High Dose (HD) in Participants with Diabetic Macular Edema (ALVOEYE-HD)

Latvia, Slovakia, Czechia, Hungary, Poland, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multi-Center, Randomized, Parallel-Group, Phase 2, Masked, Three-Arm Trial to Compare Safety, Tolerability, Efficacy, and Durability of Two Dose Levels of Suprachoroidal Sustained-Release OXU-001 (Dexamethasone Microspheres; DEXAspheres®) Using the Oxulumis® Illuminated Microcatheterization Device Compared with Intravitreal Dexamethasone Implant (OZURDEX®) in Subjects with Diabetic Macular Edema (OXEYE).

Hungary, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

Italy, France, Germany, Spain, Czechia, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants with Diabetic Macular Edema (DME) (EYP-1901-303)

Germany, Poland, Slovakia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants with Diabetic Macular Edema (DME) (EYP-1901-304)

Hungary, Czechia, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Diabetic Macular Edema Dme trials by city

Diabetic Macular Edema Dme in Toronto Diabetic Macular Edema Dme in Vancouver Diabetic Macular Edema Dme in Montreal Diabetic Macular Edema Dme in Calgary Diabetic Macular Edema Dme in Edmonton Diabetic Macular Edema Dme in Ottawa Diabetic Macular Edema Dme in Winnipeg Diabetic Macular Edema Dme in Quebec City Diabetic Macular Edema Dme in Hamilton Diabetic Macular Edema Dme in Kitchener Diabetic Macular Edema Dme in London Diabetic Macular Edema Dme in Halifax Diabetic Macular Edema Dme in New York Diabetic Macular Edema Dme in Los Angeles Diabetic Macular Edema Dme in Chicago Diabetic Macular Edema Dme in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease